Playback speed
10 seconds
2020 Update on Statin Therapy in ASCVD: Why Does Residual Risk Occur in Clinical Practice? Can the Big Data Asist in Identifying Patients With SASEs? Why Are System-Level Interventions Needed?
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Salim Virani
By
Cardiometabolic Health Congress (CMHC)
FEATURING
Salim Virani
121 views
September 22, 2020
Login to view comments.
Click here to Login